CRM
60
3
AIV
54
3
CTAS
59
6
FOXA
59
-4
SEE
49
3
NAVI
58
15
EMR
76
6
EOG
55
6
MDLZ
30
-8
AEP
42
-6
ROST
54
-3
MCHP
43
-2
SYY
47
2
VFC
61
-4
MTCH
59
4
SBUX
32
-3
MHK
52
7
COP
57
4
MAT
47
-12
PNC
65
10
CRM
60
3
AIV
54
3
CTAS
59
6
FOXA
59
-4
SEE
49
3
NAVI
58
15
EMR
76
6
EOG
55
6
MDLZ
30
-8
AEP
42
-6
ROST
54
-3
MCHP
43
-2
SYY
47
2
VFC
61
-4
MTCH
59
4
SBUX
32
-3
MHK
52
7
COP
57
4
MAT
47
-12
PNC
65
10
Financhill
Back

Verve Therapeutics Stock Predictions

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
1

VERV
Verve Therapeutics

Last Price:
6.39
Seasonality Move:
-35.34%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Verve Therapeutics Stock Forecast

  • Over the next 52 weeks, Verve Therapeutics has on average historically fallen by 51.2% based on the past 3 years of stock performance.
  • Verve Therapeutics has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
  • Is Verve Therapeutics Stock Undervalued?
    The current Verve Therapeutics [VERV] share price is $6.42. The Score for VERV is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • VERV is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Verve Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Verve Therapeutics has on average historically fallen by 51.2% based on the past 3 years of stock performance.

Verve Therapeutics Stock Rating

Sell
1
Verve Therapeutics (VERV) is a Sell

Is Verve Therapeutics overpriced?

  • Verve Therapeutics has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%

Verve Therapeutics Stock Price History

Is VERV stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VERV is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vervetx.com

52-Week Data

52-Week High:
20.12
52-Week Low:
4.31

Prediction Charts

Market Cap:
543.54M
Price in USD:
6.42
Volume:
1.31M
Beta:
1.79

Technical Analysis

SMA50:
5.46
SMA100:
5.64
SMA200:
7.67
52-Wk Change:
-57.14%

Stock Predictions

  • Is Verve Therapeutics stock public?
    Yes, Verve Therapeutics is a publicly traded company.
  • What is the Verve Therapeutics stock quote today?
    The Verve Therapeutics stock price is 6.42 USD today.
  • How to buy Verve Therapeutics stock online?
    You can buy Verve Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-18 5.47 5.65 5.74 5.39
Oct-21 5.65 5.55 5.68 5.44
Oct-22 5.52 5.69 5.71 5.30
Oct-23 5.67 5.54 5.71 5.42
Oct-24 5.54 5.72 6.02 5.45
Oct-25 5.72 5.97 6.09 5.72
Oct-28 6.01 5.94 6.45 5.93
Oct-29 5.95 6.00 6.18 5.88
Oct-30 5.92 5.80 6.14 5.68
Oct-31 5.77 5.73 5.83 5.62
Nov-1 5.73 5.93 5.96 5.65
Nov-4 5.95 6.04 6.17 5.62
Nov-5 6.19 6.38 6.77 6.14
Nov-6 6.45 6.42 6.81 6.28

Verve Therapeutics Earnings

Verve Therapeutics Earnings Report: Per Share Verve Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Verve Therapeutics Forecast Revenue Growth

Verve Therapeutics Stock Analysis: Historical quarterly revenues per share for Verve Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.78 per share, and a decrease next year of $0.43 per share.

* Verve Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.